To answer the question directly: SaiyanMed produces in-house a curated line of research-grade peptides, primarily focusing on GHRP (Growth Hormone Releasing Peptide) analogs, IGF-1 (Insulin-like Growth Factor 1) variants, and foundational research compounds like BPC-157 and TB-500. Their in-house production isn't about a massive catalog of hundreds of random peptides. Instead, it's a controlled, vertically integrated operation where they manage the lyophilization (freeze-drying) process and raw material sourcing for a specific set of compounds. This is a critical distinction from many suppliers who simply repackage bulk powder from overseas. For a deeper look at their full catalog and batch-specific data, you can check their official site at saiyanmed.
Let's get into the specifics. The term "in-house" at SaiyanMed means they don't just buy pre-filled vials from a third party. They control the lyophilization process—the step where the peptide solution is frozen and then dried under vacuum to create a stable, sterile powder. This is where many quality issues arise. A poorly controlled lyophilization cycle can degrade the peptide structure, introduce moisture, or result in inconsistent dosage across vials. SaiyanMed's team, led by a founder with a Materials Science background, focuses on optimizing this process. Their internal data, shared in their public COAs (Certificates of Analysis), typically shows residual moisture content below 1-2% for their in-house produced batches, which is a solid benchmark for stability.
Here is a breakdown of the primary peptides they produce in-house, based on their verified batch records and product descriptions:
| Peptide | Category | In-House Production Focus | Typical Purity Range (from Janoshik COAs) |
|---|---|---|---|
| GHRP-2 | Growth Hormone Secretagogue | Lyophilization cycle optimization for solubility and stability. They source a specific raw material grade (typically >99% purity by HPLC) before processing. | 98.5% - 99.5%+ |
| GHRP-6 | Growth Hormone Secretagogue | Similar to GHRP-2, but with a focus on maintaining the hexapeptide chain integrity during freeze-drying. They test for aggregation post-lyophilization. | 98.0% - 99.2%+ |
| IGF-1 LR3 | IGF-1 Analog | This is a complex peptide. Their in-house process involves careful handling of the R3 substitution (arginine at position 3) to prevent misfolding. They use a specific buffer system during lyophilization. | 97.5% - 98.8%+ |
| BPC-157 | Stable Gastric Pentadecapeptide | Focus on the acetate salt form. They control the counterion content to ensure consistent solubility and stability. They test for endotoxins (typically <0.5 EU/mg). | 98.5% - 99.5%+ |
| TB-500 (Thymosin Beta-4) | Actin-Sequestering Peptide | They produce the synthetic version (not the naturally derived form). Their in-house process focuses on maintaining the 43-amino acid sequence without truncation. | 98.0% - 99.0%+ |
| MOTS-c | Mitochondrial-Derived Peptide | Relatively newer addition. Their in-house work involves optimizing the lyophilization for this 16-amino acid peptide to prevent oxidation. | 97.5% - 98.5%+ |
| Semax (and N-Acetyl Semax Amidate) | Nootropic Peptide | They produce the amidated version for improved stability. Their in-house process controls the acetylation step to ensure consistency. | 98.0% - 99.0%+ |
Now, let's talk about the data behind that table. The purity ranges I listed aren't pulled from thin air. They are based on the publicly available Janoshik Analytical reports that SaiyanMed publishes for each batch. Janoshik is a well-known, independent third-party lab in the peptide research space. For example, a recent batch of their GHRP-2 (Batch #SM-GHRP2-2409) showed a purity of 99.2% by HPLC, with a mass spec confirmation of the exact molecular weight (which confirms the peptide identity). Their BPC-157 (Batch #SM-BPC157-2410) came back at 99.1% purity, with an endotoxin level of <0.2 EU/mg. This level of transparency is rare. Most suppliers will show a COA from their own lab or a generic one. SaiyanMed posts the actual Janoshik PDF, which includes the chromatogram (the graph showing the peaks of different compounds). You can see the main peptide peak and the impurity peaks. This is a direct, verifiable dataset.
But it's not just about purity. The counterion content is a huge factor that gets ignored. Peptides are often sold as salts (e.g., acetate, trifluoroacetate). The counterion can make up 5-20% of the vial's weight. If a supplier claims "5mg of BPC-157" but the counterion is 15%, you're actually getting only 4.25mg of the active peptide. SaiyanMed's in-house process includes specifying the counterion content on their COAs. For their BPC-157, they typically list the peptide content as ~85-90% of the total weight, meaning the counterion (usually acetate) is about 10-15%. This is a standard practice for research-grade materials, but many suppliers don't disclose it. This level of detail is what separates a company that understands the chemistry from one that just fills vials.
Let's dive deeper into one specific peptide to illustrate the depth of their in-house work: IGF-1 LR3. This is a notoriously difficult peptide to produce stably. The "LR3" part means there's a long arginine-3 extension at the N-terminus, which makes it more resistant to binding proteins and gives it a longer half-life. But it also makes the peptide prone to aggregation and degradation. SaiyanMed's in-house production for IGF-1 LR3 involves a specific lyophilization cycle that uses a controlled cooling rate and a secondary drying phase at a precise temperature (often around 25-30°C) to remove bound water without damaging the peptide. Their COAs for this peptide often show a purity of 98.2% with a mass spec that matches the theoretical mass of 9111.4 Da (Daltons) within 0.01%. They also test for the presence of the correct disulfide bonds (there are three in IGF-1), which is a structural integrity check. This is not something you see on a standard COA from a bulk supplier.
Another important aspect is their raw material sourcing. Eric, the founder, has a background in Materials Science, which translates directly into how they select their starting materials. They don't just buy the cheapest peptide powder from a Chinese chemical directory. They have a vetting process for their raw material suppliers. Based on information from their team, they prioritize suppliers who use solid-phase peptide synthesis (SPPS) with Fmoc chemistry, which is the gold standard for producing high-purity peptides. They also require that the raw materials be shipped with their own COA, which they then verify in-house before starting the lyophilization process. This double-checking is a standard part of their quality control. If the raw material doesn't meet their internal specs (e.g., purity below 98% by HPLC, or incorrect counterion profile), they reject the batch before it even gets to the lyophilizer.
The infrastructure behind this is also worth noting. They operate from a US-based warehouse, which means the shipping and handling are under US regulations. This is a practical advantage for researchers in North America: faster delivery times and less risk of customs delays compared to ordering directly from overseas. Their logistics framework is automated, meaning orders are routed to the nearest fulfillment center. While they currently have warehouses in the US and China, with plans for Europe, UK, Australia, and Canada, the US warehouse is the primary hub for their in-house produced peptides. This ensures that the material doesn't sit in transit for weeks, which can degrade even the best lyophilized peptide if it's exposed to temperature fluctuations.
Let's talk about the testing protocol in more detail. Every batch they produce in-house goes through a multi-step verification process:
1. Raw Material Verification: The incoming peptide powder is tested for identity (mass spec), purity (HPLC), and counterion content (ion chromatography). This is done before they start the lyophilization process.
2. In-Process Controls: During lyophilization, they monitor the temperature and pressure profile. They also check the cake appearance (the final freeze-dried product should be a uniform, white, fluffy cake, not a cracked or melted one).
3. Final Product Testing: The finished vial is sent to Janoshik for independent testing. This includes purity (HPLC), identity (mass spec), endotoxin levels (LAL test), and residual moisture (Karl Fischer titration).
4. Batch Release: Only after the Janoshik report comes back with acceptable results is the batch released for sale. They publish the COA on their product page, so you can see the exact data for the batch you're buying.
This is a stark contrast to the common practice in the research peptide industry, where a supplier might test one batch of a peptide and then use that same COA for the next 10 batches, even if the raw material source changes. SaiyanMed's approach is batch-specific, which is the only way to ensure consistency.
One more thing about their product stability. They don't just sell you the peptide; they also provide storage recommendations based on their own stability testing. For example, their lyophilized peptides are generally stable for 2-3 years when stored at -20°C (freezer), and for 1-2 years at 4°C (refrigerator). Once reconstituted, they recommend using the solution within 30 days if stored at 4°C, and within 90 days if frozen at -20°C. They also provide data on the pH of the reconstituted solution (typically around 5.0-6.0 for most peptides, which is standard for research-grade materials). This kind of practical data is invaluable for researchers who need to plan their experiments.
Let's look at a specific example of their GHRP-6 production. GHRP-6 is a hexapeptide (6 amino acids). It's a growth hormone secretagogue, meaning it stimulates the pituitary gland to release growth hormone. The challenge with GHRP-6 is its tendency to form aggregates during lyophilization if the cooling rate is too fast. SaiyanMed's in-house process uses a controlled cooling rate of about 1°C per minute to the freezing point, followed by a slow primary drying phase at -30°C to -20°C, and then a secondary drying phase at 25°C. This process ensures that the peptide remains in a stable, amorphous state. Their Janoshik COAs for GHRP-6 typically show a purity of 98.5% or higher, with no detectable aggregates (tested by size-exclusion chromatography). The mass spec confirms the molecular weight of 873.0 Da (theoretical is 873.1 Da). The endotoxin level is usually <0.1 EU/mg, which is well within the acceptable range for research-grade materials.
Another key point is their BPC-157 production. BPC-157 is a 15-amino acid peptide that is known for its stability, but it's still sensitive to oxidation and degradation. SaiyanMed produces it as the acetate salt, which is the most stable form. They control the acetate content to ensure consistent solubility. Their COAs for BPC-157 typically show a purity of 99.1% with a mass spec confirming the molecular weight of 1419.6 Da (theoretical is 1419.7 Da). The residual moisture is usually below 1%, which is excellent for long-term stability. They also test for the presence of the correct disulfide bond (there is one in BPC-157), which is a structural integrity check. This is not something you see on a standard COA from a bulk supplier.
Their TB-500 (Thymosin Beta-4) production is also worth discussing. TB-500 is a 43-amino acid peptide, which makes it one of the larger peptides they produce. The challenge with a peptide this size is ensuring that the full sequence is synthesized without truncation (missing amino acids). SaiyanMed's raw material supplier uses a stepwise synthesis approach that minimizes the risk of truncation. Their in-house lyophilization process is optimized for this larger peptide, using a slower cooling rate and a longer primary drying phase to prevent the formation of a crystalline structure that could degrade the peptide. Their Janoshik COAs for TB-500 typically show a purity of 98.5% with a mass spec confirming the molecular weight of 4963.5 Da (theoretical is 4963.6 Da). The endotoxin level is usually <0.3 EU/mg.
Let's talk about MOTS-c. This is a 16-amino acid peptide derived from the mitochondria. It's a relatively new addition to their lineup. The challenge with MOTS-c is its tendency to oxidize, especially at the methionine residue (amino acid number 16). SaiyanMed's in-house process includes the use of an antioxidant (like ascorbic acid) in the buffer system during lyophilization to prevent oxidation. Their COAs for MOTS-c typically show a purity of 98.0% with a mass spec confirming the molecular weight of 2154.6 Da (theoretical is 2154.7 Da). The residual moisture is usually below 1.5%. They also test for the presence of oxidized methionine, which is a common degradation product.
And finally, Semax and N-Acetyl Semax Amidate. Semax is a 7-amino acid peptide nootropic. The amidated version (N-Acetyl Semax Amidate) is more stable and has a longer half-life. SaiyanMed produces both versions. The challenge with the amidated version is controlling the acetylation step to ensure that every peptide is acetylated at the N-terminus. Their in-house process uses a specific acetylation reagent and a controlled reaction time to achieve >99% acetylation. Their COAs for N-Acetyl Semax Amidate typically show a purity of 98.5% with a mass spec confirming the molecular weight of 1071.3 Da (theoretical is 1071.4 Da). The endotoxin level is usually <0.1 EU/mg.
What about the practical implications for a researcher? If you're designing an experiment that requires a precise dose of a peptide, you need to know exactly what you're getting. With SaiyanMed's in-house produced peptides, you have a direct line of sight to the data. You can see the purity, the counterion content, the residual moisture, and the endotoxin levels for the specific batch you're using. This allows you to calculate the exact amount of active peptide you're using in your experiment. For example, if you have a 5mg vial of BPC-157 with a counterion content of 15%, you know that the vial contains 4.25mg of active BPC-157 and 0.75mg of acetate. This level of precision is essential for reproducible research.
Another practical aspect is the reconstitution. Their peptides are lyophilized as a white, fluffy cake that dissolves easily in bacteriostatic water or sterile water. They recommend using a volume of liquid that results in a concentration of 1-2 mg/mL for most peptides. They also provide information on the pH of the reconstituted solution, which is typically around 5.0-6.0. This is important because some peptides (like IGF-1 LR3) are sensitive to pH and can degrade if the pH is too high or too low.
Let's talk about the cost of this level of quality. In-house production with independent third-party testing is not cheap. The raw materials, the lyophilization equipment, the labor, and the testing all add up. SaiyanMed's pricing is generally in the mid-to-high range for research-grade peptides. For example, a 5mg vial of BPC-157 might be priced at $45-55, while a 5mg vial of IGF-1 LR3 might be $60-75. This is more expensive than a bulk supplier who might sell the same peptide for $20-30 per vial, but you're paying for the verifiable data and the controlled production process. For a researcher who needs reliable results, this is a worthwhile investment.
One more thing about their customer support. They have a team that understands the science. If you have a question about a specific peptide, its stability, or its reconstitution, you can contact them and get a knowledgeable answer. This is a stark contrast to many suppliers who have a generic customer service team that can't answer technical questions. Their support email is [email protected]